It's getting harder for me not to view Agilent (NYSE:A) as something like the store-brand version of Danaher (NYSE:DHR).
It's cheaper and pretty close to the real thing, but it's just not
quite the same and sometimes those differences leave you walking away
unsatisified. To be sure, I think Agilent could do a lot to close this
gap, but I'm not sure they will. Consequently, while Agilent is a little
bit undervalued, it's harder for me to be as enthusiastic about buying
shares today – particularly when Danaher seems undervalued to a similar
degree.
To continue, please follow this link:
http://www.investopedia.com/stock-analysis/051513/agilent-isnt-making-it-easy-investors-dhr-ter-nati-wat.aspx
No comments:
Post a Comment